MEIRAGTX HLDGS PLC's ticker is MGTX and the CUSIP is G59665102. A total of 37 filers reported holding MEIRAGTX HLDGS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,898,550 | $38,957,000 | 21.20% |
| Prosight Management, LP | 568,348 | $7,639,000 | 3.57% |
| Perceptive Advisors | 6,433,277 | $86,463,000 | 2.25% |
| Orbimed Advisors | 3,582,320 | $48,146,000 | 0.81% |
| Parkman Healthcare Partners LLC | 125,000 | $1,680,000 | 0.78% |
| 683 Capital Management, LLC | 831,748 | $11,178,000 | 0.66% |
| Claraphi Advisory Network, LLC | 98,850 | $1,329,000 | 0.63% |
| Fort Sheridan Advisors LLC | 54,512 | $733,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 246,307 | $3,310,000 | 0.46% |
| PA Capital LLC | 39,039 | $525,000 | 0.46% |